What is the desired urinary output when monitoring a patient on magnesium sulfate treatment?

What is the desired urinary output when monitoring a patient on magnesium sulfate treatment?

• A. 30-40 ml/hr
• B. 20-25 ml/hr
• C. 25-30 ml/hr
• D. 15-20 ml/hr

Answer: (C)

The desired urinary output when monitoring a patient on magnesium sulfate treatment is typically around 25-30 ml/hr. This range is important as it indicates adequate kidney function and helps ensure that the patient is effectively excreting magnesium. During magnesium sulfate therapy, the risk of hypermagnesemia increases, which can lead to complications including respiratory depression and cardiac arrest. Monitoring urinary output is crucial because it provides valuable insight into the body’s ability to excrete excess magnesium, thereby preventing potential toxicity. In general, variations in urinary output can signify shifts in renal function or fluid balance, making it essential to maintain output at or above the recommended level during treatment. Lower urinary outputs could indicate decreased renal perfusion or toxicity, which requires prompt assessment and intervention.

The desired urinary output when monitoring a patient on magnesium sulfate treatment is typically around 25-30 ml/hr. This range is important as it indicates adequate kidney function and helps ensure that the patient is effectively excreting magnesium. During magnesium sulfate therapy, the risk of hypermagnesemia increases, which can lead to complications including respiratory depression and cardiac arrest. Monitoring urinary output is crucial because it provides valuable insight into the body’s ability to excrete excess magnesium, thereby preventing potential toxicity.

In general, variations in urinary output can signify shifts in renal function or fluid balance, making it essential to maintain output at or above the recommended level during treatment. Lower urinary outputs could indicate decreased renal perfusion or toxicity, which requires prompt assessment and intervention.